Pfizer : PFE

All Pfizer Articles

1465 Articles

Lee Jackson | Apr 7, 2016 at 8:55 AM EDT

Top Analysts Upgrade and Downgrades: Apple, Coach, EMC, Hewlett Packard Enterprise, Pfizer, Verizon and More

Thursday's top analyst upgrades, downgrades and initiations include Apple, Coach, EMC, Hewlett Packard Enterprise, Pfizer and Verizon.

Paul Ausick | Apr 6, 2016 at 4:01 PM EDT

The 4 Stocks That Dominated the Dow on Wednesday

April 6, 2016: Markets opened higher on Wednesday following mixed trading in Asia. The dollar weakened and the release of…

Douglas A. McIntyre | Apr 5, 2016 at 5:17 PM EDT

Big Company Executives Attack Government on Inversion Stance

The Business Roundtable, the primary representatives of the CEOs of America's largest companies, made a statement about business combinations that…

Chris Lange | Apr 3, 2016 at 10:10 AM EDT

The 6 Dow Stocks Holding the Market Down in 2016

After much waiting, the broad markets and the Dow Jones Industrial Average in particular have made it back to positive…

Paul Ausick | Apr 1, 2016 at 4:01 PM EDT

The 4 Stocks That Lifted the DJIA on Friday

ThinkstockApril 1, 2016: Markets opened lower on Friday following the monthly employment report from the Bureau of Labor Statistics. The…

Paul Ausick | Mar 31, 2016 at 4:01 PM EDT

The 4 Stocks That Weighed Down the DJIA on Thursday

March 31, 2016: Markets opened higher again on Thursday but only the Nasdaq Composite was able to hold on for…

Lee Jackson | Mar 30, 2016 at 11:05 AM EDT

Top Dividend-Paying Pharmaceutical Stocks Rated Buy by Analysts

Long-term growth investors looking for a degree of safety and value should consider some of these outstanding companies. While the…

Trey Thoelcke | Mar 25, 2016 at 6:20 AM EDT

The 5 Most Shorted NYSE Stocks: Pfizer Surges to the Top

Interest in almost all of the most heavily shorted stocks traded on the New York Stock Exchange shrank between the…

Paul Ausick | Mar 21, 2016 at 4:01 PM EDT

The 4 Stocks That Buoyed the Dow on Monday

March 21, 2016: Markets opened lower on Monday on some weakness overnight in oil prices. The morning report on existing…

Chris Lange | Mar 18, 2016 at 12:40 PM EDT

Pfizer Posts Positive Late-Stage Results in Colitis Trials

Pfizer announced the results from its first two pivotal Phase 3 studies from the Oral Clinical Trials for tofacitinib in…

Lee Jackson | Mar 18, 2016 at 8:25 AM EDT

4 Merrill Lynch US 1 Dividend Stocks to Buy for Continued Low Rates

So what are investors to do in a continued low rate environment? Buy the best stocks out there, especially ones…

Chris Lange | Mar 15, 2016 at 10:20 AM EDT

Huge Opportunity, and Risks, in 5 Top Abuse-Deterrent ER Opioids

One analyst firm believes the development of abuse-deterrent formulations (ADF) of opioids creates a risk that older non-ADFs may be…

Chris Lange | Mar 15, 2016 at 9:25 AM EDT

Jefferies Top Drug Stocks for the Rest of 2016

For the most part, Jefferies maintained its list of top companies in the health care sector, but it also made…

Paul Ausick | Mar 11, 2016 at 4:01 PM EST

The 4 Stocks That Dominated the Dow on Friday

March 11, 2016: Markets opened higher again on Friday and held on to the early gains all day. Energy and…

Lee Jackson | Mar 11, 2016 at 8:35 AM EST

Merrill Lynch Has 4 Outstanding Growth Stocks to Buy That Yield More Than 4%

24/7 Wall St. screened the Merrill Lynch research data base for solid growth ideas that also paid a dividend of…

1 … 49 50 51 52 53 … 98

Pfizer : PFE

All Pfizer Articles

Top Analysts Upgrade and Downgrades: Apple, Coach, EMC, Hewlett Packard Enterprise, Pfizer, Verizon and More

The 4 Stocks That Dominated the Dow on Wednesday

Big Company Executives Attack Government on Inversion Stance

The 6 Dow Stocks Holding the Market Down in 2016

The 4 Stocks That Lifted the DJIA on Friday

The 4 Stocks That Weighed Down the DJIA on Thursday

Top Dividend-Paying Pharmaceutical Stocks Rated Buy by Analysts

The 5 Most Shorted NYSE Stocks: Pfizer Surges to the Top

The 4 Stocks That Buoyed the Dow on Monday

Pfizer Posts Positive Late-Stage Results in Colitis Trials

4 Merrill Lynch US 1 Dividend Stocks to Buy for Continued Low Rates

Huge Opportunity, and Risks, in 5 Top Abuse-Deterrent ER Opioids

Jefferies Top Drug Stocks for the Rest of 2016

The 4 Stocks That Dominated the Dow on Friday

Merrill Lynch Has 4 Outstanding Growth Stocks to Buy That Yield More Than 4%

7 Reasons Why Wall Street May Regret Trump Nominating Kevin Warsh for Fed Chair

This Overlooked Precious Metals ETF Offers a 7% Yield

Why Gold Won’t Save You in a Real Crisis (But Stocks Will)

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

7 Reasons Why Wall Street May Regret Trump Nominating Kevin Warsh for Fed Chair

This Overlooked Precious Metals ETF Offers a 7% Yield

Pfizer : PFE

All Pfizer Articles

Top Analysts Upgrade and Downgrades: Apple, Coach, EMC, Hewlett Packard Enterprise, Pfizer, Verizon and More

The 4 Stocks That Dominated the Dow on Wednesday

Big Company Executives Attack Government on Inversion Stance

The 6 Dow Stocks Holding the Market Down in 2016

The 4 Stocks That Lifted the DJIA on Friday

The 4 Stocks That Weighed Down the DJIA on Thursday

Top Dividend-Paying Pharmaceutical Stocks Rated Buy by Analysts

The 5 Most Shorted NYSE Stocks: Pfizer Surges to the Top

The 4 Stocks That Buoyed the Dow on Monday

Pfizer Posts Positive Late-Stage Results in Colitis Trials

4 Merrill Lynch US 1 Dividend Stocks to Buy for Continued Low Rates

Huge Opportunity, and Risks, in 5 Top Abuse-Deterrent ER Opioids

Jefferies Top Drug Stocks for the Rest of 2016

The 4 Stocks That Dominated the Dow on Friday

Merrill Lynch Has 4 Outstanding Growth Stocks to Buy That Yield More Than 4%

7 Reasons Why Wall Street May Regret Trump Nominating Kevin Warsh for Fed Chair

This Overlooked Precious Metals ETF Offers a 7% Yield

Why Gold Won’t Save You in a Real Crisis (But Stocks Will)

Featured Reads

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up